作者: Mathew Q. Fakhoury , Antoine M. Ghorayeb , Matthew D. Houlihan , Ryan J Powers , Stephen Hurley
DOI: 10.1016/J.UROLOGY.2020.05.089
关键词: Medicine 、 Urologic Oncology 、 Malignancy 、 Internal medicine 、 Psychosocial 、 Anxiety 、 Depression (differential diagnoses) 、 Pharmacotherapy 、 Risk factor 、 Smoking cessation
摘要: Objective To determine risk factors for continued smoking following a diagnosis of genitourinary (GU) malignancy. Smoking is well established factor in the development cancers involving GU tract. Unfortunately, large percentage patients continue to smoke or relapse after cancer diagnosis; by doing so, there an increased recurrence, poor survival rates, treatment complications, secondary primary cancers, and other chronic related illnesses. Materials Methods Two hundred five who presented Urologic Oncology clinic at single tertiary center were given cessation counseling pharmacotherapy, as questionnaire which was used identify status, demographics, behavioral/psychosocial characteristics. Patients followed minimum 1 year with median length follow up 13 months. Results 91% enrolled study survey completion. After accounting age, ethnicity, education cigarettes consumed/day, 5 variables independently associated smoking: 20 more per day, less than 2 prior quit attempts, anxiety and/or depression, fear home secondhand exposure. Conclusion The role urologist imperative encouraging cessation. While every patient should receive adequate regarding time malignancy diagnosis, identifying noted this augmenting efforts may result stronger prevention long-term complications.